W H E N E FF E
MILD TO MO CTIVE RELIEF
INFLAM MAT DERATE PAIN O OF
WITHOUT F ORY ORIGIN WI F
EVER IS N TH 1, OR
EEDED 2
Myprodo
l’s
COMBIN original formulati
ES THE
on
DIFF
ACTIONS
of codein ERENT
e, ibupro
and para
fen
cetamol
in an OP
RATIO O
T
IMISED
F 1:20:2
5 for effe
of pain,
ctive reli
infl amma
ef
tion and
Myprodo
fever. 1,2
l suspen
sio
a pleasa
nt blackc n is available in
urrant fl a
vour. 2
?
T
N
E
M
O
M
L
O
D
O
R
P
MY
®
My patient. My reputation. Myprodol ® .
References: 1. Mitchell D, Gelgor L, Weber J. Antihypernociceptive synergy between ibuprofen, paracetamol and codeine in rats. European Journal of Pharmacology
2010;642:86-92. 2. Myprodol ® Suspension approved package insert, June 1994.
MYPRODOL ® Suspension. Each 10 ml contains codeine phosphate 10 mg; ibuprofen 200 mg; paracetamol 250 mg. Reg. No. Y/2.8/119. For full prescribing information
refer to the package insert approved by the medicines regulatory authority. 1023659 02/2017. Adcock Ingram Limited. Reg. No. 1949/034385/06. Private Bag X69, Bryan-
ston, 2021, South Africa. Tel. +27 11 635 0000. www.adcock.com